Cited by 26Genetics and Neurodevelopmental DisordersMicroRNA in disease regulationNeuroscience and Neuropharmacology Research

Astroglial FMRP deficiency cell-autonomously up-regulates miR-128 and disrupts developmental astroglial mGluR5 signaling.

Open access
Men, Yuqin, Ye, Liang, Risgaard, Ryan D., Promes, Vanessa, Zhao, Xinyu, Paukert, Martin, Yang, Yongjie·2020·Proceedings of the National Academy of Sciences

Abstract

The loss of fragile X mental retardation protein (FMRP) causes fragile X syndrome (FXS), the most common inherited intellectual disability. How the loss of FMRP alters protein expression and astroglial functions remains essentially unknown. Here we showed that selective loss of astroglial FMRP in vivo up-regulates a brain-enriched miRNA, miR-128-3p, in mouse and human FMRP-deficient astroglia, which suppresses developmental expression of astroglial metabotropic glutamate receptor 5 (mGluR5), a major receptor in mediating developmental astroglia to neuron communication. Selective in vivo inhibition of miR-128-3p in FMRP-deficient astroglia sufficiently rescues decreased mGluR5 function, while astroglial overexpression of miR-128-3p strongly and selectively diminishes developmental astroglial mGluR5 signaling. Subsequent transcriptome and proteome profiling further suggests that FMRP commonly and preferentially regulates protein expression through posttranscriptional, but not transcriptional, mechanisms in astroglia. Overall, our study defines an FMRP-dependent cell-autonomous miR pathway that selectively alters developmental astroglial mGluR5 signaling, unveiling astroglial molecular mechanisms involved in FXS pathogenesis.

Integrity signals

Registry

Crossref · 10.1073/pnas.2014080117

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • mGluR5 regulates GLT-1 expression in astrocytes, and reduced mGluR5 expression has been found in both human and mouse FMRP-deficient astrocytes.

    “mGluR5 regulates GLT-1 expression in astrocytes and reduced mGluR5 expression has been found both in human and mouse FMRP-deficient astrocytes (Higashimori et al., 2013; Men et al., 2020).”

    From Astrocytes in fragile X syndrome (2024) · cites this paper as Men et al., 2020

  • Selective astroglial overexpression of miRNA-128 results in reduced mGluR5 protein in FMRP-deficient astrocytes.

    “Selective astroglial overexpression of miRNA-128 results in reduced mGluR5 protein in FMRP-deficient astrocytes (Men et al., 2020).”

    From Astrocytes in fragile X syndrome (2024) · cites this paper as Men et al., 2020

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Men, Y., Ye, L., Risgaard, R. D., Promes, V., Zhao, X., Paukert, M., & Yang, Y.
Affiliations
  • Tufts University (US)
  • The University of Texas at San Antonio Health Science Center (US)
  • University of Wisconsin–Madison (US)
Corresponding author
Yang, Yongjie
Venue
Proceedings of the National Academy of Sciences
Published
2020-09-21
Volume
117
Issue
40
Pages
25092-25103
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W3087653991
Cited by
26
References
6
Citations by year
2026: 4 · 2025: 3 · 2024: 6 · 2023: 1 · 2022: 6 · 2021: 6
FWCI
1.91
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • NIH (MH106490, MH116582, NS105339, MH113780)
  • Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation (N/A)
  • FRAXA Research Foundation (N/A)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
fragile X syndrome, FMRP, astroglia, miR-128-3p, metabotropic glutamate receptor 5, microRNA regulation, post-transcriptional regulation, intellectual disability
MeSH terms
Animals, Astrocytes, Disease Models, Animal, Fragile X Syndrome, Humans, Neurons, Signal Transduction, Transcriptional Activation, MicroRNAs, Mice, Fragile X Mental Retardation Protein, Fragile X Messenger Ribonucleoprotein 1, Receptor, Metabotropic Glutamate 5

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review